학술논문

Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Document Type
Article
Source
Hematological Oncology; Dec2022, Vol. 40 Issue 5, p941-952, 12p
Subject
CYTOTOXIC T cells
KILLER cells
LYMPHOMAS
HODGKIN'S disease
NON-Hodgkin's lymphoma
Language
ISSN
02780232
Abstract
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)